propiolactone has been researched along with Viremia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abduraimov, Y; Bulatov, Y; Koshemetov, Z; Renukaradhya, GJ; Tabynov, K; Taranov, D; Yershebulov, Z; Zhugunissov, K; Zhunushov, A | 1 |
1 other study(ies) available for propiolactone and Viremia
| Article | Year |
|---|---|
Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Neutralizing; Antibodies, Viral; Bluetongue; Bluetongue virus; Drug Storage; Propiolactone; Serogroup; Sheep; Time Factors; Vaccine Potency; Vaccines, Inactivated; Viral Load; Viral Vaccines; Viremia | 2018 |